Target intelligence / Profile preview

RNA, U6 small nuclear 151, pseudogene (RNU6-151P)

Target
RNU6-151P
Molecular classification
Processed pseudogene
01

Overview

RNU6-151P is a processed pseudogene related to the U6 small nuclear RNA (snRNA) family. U6 snRNAs are core components of spliceosomes and essential for pre-mRNA splicing[1][3]. Pseudogenes like RNU6-151P are formed through retrotransposition events and do not produce functional RNA or protein; they are generally considered non-functional and serve as genetic remnants or markers for genome evolution and transposable element activity[5]. While some pseudogenes participate in gene regulation or disease (often by acting as RNA sponges), there is no evidence that RNU6-151P fulfills such functions[2][4]. It is annotated in the human genome but has no known biological, pharmacological, or clinical relevance. Key points: - RNU6-151P is not a therapeutic target, enzyme, receptor, or biomarker. - It is a pseudogene, meaning it is a genomic sequence resembling a functional gene but lacking protein-coding or regulatory activity. - No drugs, mechanisms, or disease associations are documented for this specific pseudogene. - The entry is scientifically correct but not useful for therapeutic targeting purposes.

Other names
RNU6-151P
02

Biological functions

Non-functional pseudogeneDoes not code for active RNA or protein
03

Disease associations

No established role in disease

Beyond the preview

Go deeper on RNA, U6 small nuclear 151, pseudogene (RNU6-151P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 151, pseudogene (RNU6-151P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call